1. Home
  2. SER vs AXDX Comparison

SER vs AXDX Comparison

Compare SER & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • AXDX
  • Stock Information
  • Founded
  • SER 2017
  • AXDX 1982
  • Country
  • SER United States
  • AXDX United States
  • Employees
  • SER N/A
  • AXDX N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SER Health Care
  • AXDX Industrials
  • Exchange
  • SER Nasdaq
  • AXDX Nasdaq
  • Market Cap
  • SER 46.7M
  • AXDX 41.8M
  • IPO Year
  • SER 2018
  • AXDX 1996
  • Fundamental
  • Price
  • SER $6.13
  • AXDX $1.20
  • Analyst Decision
  • SER
  • AXDX Hold
  • Analyst Count
  • SER 0
  • AXDX 1
  • Target Price
  • SER N/A
  • AXDX $1.00
  • AVG Volume (30 Days)
  • SER 37.9K
  • AXDX 63.7K
  • Earning Date
  • SER 11-12-2024
  • AXDX 11-07-2024
  • Dividend Yield
  • SER N/A
  • AXDX N/A
  • EPS Growth
  • SER N/A
  • AXDX N/A
  • EPS
  • SER N/A
  • AXDX N/A
  • Revenue
  • SER $3,157,500.00
  • AXDX $11,909,000.00
  • Revenue This Year
  • SER N/A
  • AXDX $1.50
  • Revenue Next Year
  • SER N/A
  • AXDX $4.17
  • P/E Ratio
  • SER N/A
  • AXDX N/A
  • Revenue Growth
  • SER 2454.55
  • AXDX N/A
  • 52 Week Low
  • SER $3.81
  • AXDX $0.73
  • 52 Week High
  • SER $23.18
  • AXDX $4.68
  • Technical
  • Relative Strength Index (RSI)
  • SER 58.82
  • AXDX 28.60
  • Support Level
  • SER $4.15
  • AXDX $1.32
  • Resistance Level
  • SER $6.24
  • AXDX $1.42
  • Average True Range (ATR)
  • SER 0.73
  • AXDX 0.12
  • MACD
  • SER 0.08
  • AXDX -0.04
  • Stochastic Oscillator
  • SER 84.62
  • AXDX 10.53

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Share on Social Networks: